Antonella del Valle Dan Córdoba

Mrs. Antonella del Valle Dan Córdoba

orcid

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
2 June 2020 in AAPS PharmSciTech
Verified
Journal Article
Closed access
PDF file
ACAntonella del Valle Dan Córdoba
Antonella del Valle Dan Córdoba
VAVirginia Aiassa
Virginia Aiassa
Marcela LonghiMarcela Longhi
Marcela Longhi
MQMario Alfredo Quevedo
Mario Alfredo Quevedo
AZAriana Zoppi
Ariana Zoppi

5 January 2023 in Pharmaceutics
Verified
Journal Article
Open access
PDF file
ACAntonella del Valle Dan Córdoba
Antonella del Valle Dan Córdoba
VAVirginia Aiassa
Virginia Aiassa
JDJesica Ayelen Dimmer
Jesica Ayelen Dimmer
CBCamila Nerea Barrionuevo
Camila Nerea Barrionuevo
MQMario Alfredo Quevedo
Mario Alfredo Quevedo
AZAriana Zoppi
Ariana Zoppi
Rifampicin is a potent antimicrobial drug with some suboptimal properties, such as poor stability, low solubility, and variable bioavailability. Therefore, in the current study, a multicomponent complex between rifampicin, γ-cyclodextrin, and arginine was prepared with the aim of improving drug properties. Solubility was evaluated by phase-solubility studies. The mechanism of interaction was established through proton nuclear magnetic resonance spectroscopy and molecular modeling. Physicochemical characterization was investigated using Fourier transform-infrared spectroscopy, powder X-ray diffraction, and scanning electron microscopy. The dissolution properties, antimicrobial activity (antibacterial, antibiofilm, and antileishmanial), and stability of the different samples were studied. The results obtained in this investigation demonstrate that multicomponent complexes can improve the water solubility and dissolution rate of rifampicin, as well as its antibacterial and antileishmanial action, and present suitable stability. In conclusion, rifampicin complexed with γ-cyclodextrin and arginine is an attractive approach for developing pharmaceutical dosage forms of rifampicin with increased antimicrobial activities.